Page last updated: 2024-11-02

pentoxifylline and Periodontitis

pentoxifylline has been researched along with Periodontitis in 1 studies

Periodontitis: Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)

Research Excerpts

ExcerptRelevanceReference
"Alveolar bone loss was evaluated by the sum of the distances between the cusp tip and the alveolar bone along the axis of each molar root, subtracting from the contralateral side."1.32Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats. ( Brito, GA; Lima, V; Ribeiro, RA; Rocha, FA; Vidal, FD, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lima, V1
Vidal, FD1
Rocha, FA1
Brito, GA1
Ribeiro, RA1

Other Studies

1 other study available for pentoxifylline and Periodontitis

ArticleYear
Effects of tumor necrosis factor-alpha inhibitors pentoxifylline and thalidomide on alveolar bone loss in short-term experimental periodontal disease in rats.
    Journal of periodontology, 2004, Volume: 75, Issue:1

    Topics: Alveolar Bone Loss; Analysis of Variance; Animals; Anti-Inflammatory Agents; Ligation; Male; Pentoxi

2004